Angiosarcoma cutáneo asociado a esclerosis sistémica
Palabras clave:
angiosarcoma, cutáneo, esclerosis sistémica, histología.Resumen
Se presenta el caso de una mujer de 52 años de edad con angiosarcoma cutáneo, entidad tumoral infrecuente, agresiva y de mal pronóstico, asociada con esclerosis sistémica difusa. Se discute brevemente la asociación patogénica vascular y endotelial común con factores desencadenantes de mal pronóstico, en estas dos enfermedades.
Biografía del autor/a
Natalia Montoya
Médica, residente de tercer año de Dermatología, Universidad del Valle, Cali, Colombia.
Claudia Juliana Díaz
Médica dermatóloga, docente de Dermatología, Universidad del Valle, Cali, Colombia.
Referencias bibliográficas
1. Hart A, Angeles-Albores D, et al. Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007. Ann Diagn Pathol. 2011;15:93-7.
2. Choi YJ, Rha HK, Park HK, Lee KJ, Joo WI, Kim MC. Intracranial hemorrhage in patients with hematologic disorders. J Korean Neurosurg Soc. 2004;36:302-5.
3. Estcourt LJ, Stanworth SJ, Collett D, Murphy MF. Intracranial haemorrhage in thrombocytopenic haematology patients --a nested case-control study: The InCite study protocol. BMJ Open. 2014;4:e004199.
4. Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: Interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol. 2014;66:1967-78.
5. Kubota N, Fujisawa Y, Nakamura Y, Tanaka R, Saito A, Maruyama H, et al. Angiosarcoma of the scalp in a patient with systemic sclerosis. J Dermatol. 2015;42:102-4.
6. Puizina-Ivic N, Bezic J, Marasovic D, Gotovac V, Carija A, Bozic M. Angiosarcoma arising in sclerodermatous skin. Acta Dermatovenerol Alp Pannonica Adriat. 2005;14:20-5.
7. Fonder MA, Douglas DK. Angiosarcoma complicating systemic sclerosis: A case report. Cutis. 2008;81:468-72.
8. Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Mechanisms in the loss of capillaries in systemic sclerosis: Angiogenesis versus vasculogenesis. J Cell Mol Med. 2010;14:1241-54.
9. Satoh T, Takahashi Y, Yokozeki H, Katayama I, Nishioka K. Cutaneous angiosarcoma with thrombocytopenia. J Am Acad Dermatol. 1999;40:872-6.
10. Arcomano MA, Shulkin BL, Petry NA, Wahl RL. Metastatic angiosarcoma with thrombocytopenia and intratumoral indium-111-platelet deposition. J Nucl Med. 1991;32:2278-80.
11. Arbiser JL, Larsson H, Claesson-Welsh L, Bai X, LaMontagne K, Weiss SW, et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol. 2000;156:1469-76.
12. Fujisawa Y, Yoshino K, Kadono T, Miyagawa T, Nakamura Y, Fujimoto M. Chemoradiotherapy with taxane was superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: Multicentre, retrospective study. Br J Dermatol. 2014;171:1493-500.
13. Kajihara I, Kanemaru H, Miyake T, Aoi J, Masuguchi S, Fukushima S, et al. Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel. Drug Discov Ther. 2015; 9:75-7.
14. Ravo V, Falivene S, De Chiara A, De Palma G, Pizzolorusso A, Di Franco R, et al. Treatment of cutaneous angiosarcoma of the face: Efficacy of combined chemotherapy and radiotherapy. Tumori. 2013; 99:211-5.
15. Tian XP, Zhang X, Gastrointestinal complications of systemic sclerosis. World J Gastroenterol. 2013;19:7062-8.
2. Choi YJ, Rha HK, Park HK, Lee KJ, Joo WI, Kim MC. Intracranial hemorrhage in patients with hematologic disorders. J Korean Neurosurg Soc. 2004;36:302-5.
3. Estcourt LJ, Stanworth SJ, Collett D, Murphy MF. Intracranial haemorrhage in thrombocytopenic haematology patients --a nested case-control study: The InCite study protocol. BMJ Open. 2014;4:e004199.
4. Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: Interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol. 2014;66:1967-78.
5. Kubota N, Fujisawa Y, Nakamura Y, Tanaka R, Saito A, Maruyama H, et al. Angiosarcoma of the scalp in a patient with systemic sclerosis. J Dermatol. 2015;42:102-4.
6. Puizina-Ivic N, Bezic J, Marasovic D, Gotovac V, Carija A, Bozic M. Angiosarcoma arising in sclerodermatous skin. Acta Dermatovenerol Alp Pannonica Adriat. 2005;14:20-5.
7. Fonder MA, Douglas DK. Angiosarcoma complicating systemic sclerosis: A case report. Cutis. 2008;81:468-72.
8. Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Mechanisms in the loss of capillaries in systemic sclerosis: Angiogenesis versus vasculogenesis. J Cell Mol Med. 2010;14:1241-54.
9. Satoh T, Takahashi Y, Yokozeki H, Katayama I, Nishioka K. Cutaneous angiosarcoma with thrombocytopenia. J Am Acad Dermatol. 1999;40:872-6.
10. Arcomano MA, Shulkin BL, Petry NA, Wahl RL. Metastatic angiosarcoma with thrombocytopenia and intratumoral indium-111-platelet deposition. J Nucl Med. 1991;32:2278-80.
11. Arbiser JL, Larsson H, Claesson-Welsh L, Bai X, LaMontagne K, Weiss SW, et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol. 2000;156:1469-76.
12. Fujisawa Y, Yoshino K, Kadono T, Miyagawa T, Nakamura Y, Fujimoto M. Chemoradiotherapy with taxane was superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: Multicentre, retrospective study. Br J Dermatol. 2014;171:1493-500.
13. Kajihara I, Kanemaru H, Miyake T, Aoi J, Masuguchi S, Fukushima S, et al. Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel. Drug Discov Ther. 2015; 9:75-7.
14. Ravo V, Falivene S, De Chiara A, De Palma G, Pizzolorusso A, Di Franco R, et al. Treatment of cutaneous angiosarcoma of the face: Efficacy of combined chemotherapy and radiotherapy. Tumori. 2013; 99:211-5.
15. Tian XP, Zhang X, Gastrointestinal complications of systemic sclerosis. World J Gastroenterol. 2013;19:7062-8.
Cómo citar
1.
Montoya N, Díaz CJ. Angiosarcoma cutáneo asociado a esclerosis sistémica. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 9 de agosto de 2019 [citado 26 de abril de 2024];24(2):122-6. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1103
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2019-08-09
Cómo citar
1.
Montoya N, Díaz CJ. Angiosarcoma cutáneo asociado a esclerosis sistémica. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 9 de agosto de 2019 [citado 26 de abril de 2024];24(2):122-6. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1103
Número
Sección
Reporte de caso
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
